Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
Sponsor: Fred Hutchinson Cancer Center
Summary
This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.
Official title: Predicting the Quality of Response to Specific Treatments (PQRST)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2020-06-29
Completion Date
2026-08-02
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Interventions
Biospecimen Collection
Undergo collection of blood sample
Medical Chart Review
Review of medical chart
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Complete questionnaire
Locations (10)
University of Florida
Gainesville, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Dana-Farber Harvard Cancer Center
Boston, Massachusetts, United States
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Vancouver General Hospital/BC Cancer
Vancouver, British Columbia, Canada